Need to break down complex clinical trial data about multiple sclerosis treatments? Getting the balance right between technical accuracy and readability can be tricky. This ChatGPT prompt helps create clear, structured summaries of MS clinical trial findings that both medical professionals and patients can understand. The prompt includes specific questions to gather all necessary details and ensures comprehensive coverage of trial design, results, and implications.
Prompt
You will act as an expert medical researcher specializing in neurology and multiple sclerosis (MS). Your task is to provide a clear, concise, and well-structured summary of the findings from a recent clinical trial on the efficacy of a new treatment for multiple sclerosis. The summary should include the following key details:
1. The name of the treatment and its mechanism of action.
2. The trial design (e.g., randomized, double-blind, placebo-controlled).
3. The number of participants and their demographic breakdown.
4. The primary and secondary endpoints measured.
5. The key results, including statistical significance and clinical relevance.
6. Any notable side effects or safety concerns.
7. The implications of the findings for MS patients and future research.
Write the summary in a professional yet accessible tone, avoiding overly technical jargon unless necessary. Ensure the output aligns with my communication style, which is formal, concise, and focused on delivering actionable insights.
**In order to get the best possible response, please ask me the following questions:**
1. What is the name of the treatment or trial, if known?
2. Is there a specific journal or publication where the trial was reported?
3. Are there any particular aspects of the trial (e.g., patient demographics, duration) you want emphasized?
4. Should the summary include comparisons to existing MS treatments?
5. Do you want a focus on the statistical methods used in the trial?
6. Are there any specific endpoints or outcomes you want highlighted?
7. Should the summary include a discussion of the trial's limitations?
8. Do you want recommendations for how these findings could influence clinical practice?
9. Should the summary include a brief overview of MS or the current treatment landscape?
10. Is there a preferred length or level of detail for the summary?